Overall rank by patents
#2,925
of 49,997 tracked assignees
USPTO PatentsView assignee record - 130 granted patents across 40 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Alcon ranks #2,925 of 49,997 tracked US assignees by granted-patent volume, with 130 patents across 40 technology areas.
USPTO PatentsView assignee plate
Corpus R2925 · US Corporation #2,925 · 130 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Butterfly Network, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Alcon Research · this assignee
49 score
C3 Nano · near
49 score
Discord · near
49 score
ENDRESS+HAUSER… · near
49 score
Railway Equipment · near
49 score
3D Lighting… · lowest
7 score
What this shows Alcon's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Alcon Research, Ltd. is a focused PatentsView assignee: 40 CPC subclasses with 69.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (53 grants) versus a trough of 9 in 2019. By volume, Alcon sits between THE Code Corporation and Glaxo Group Limited.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
THE Code Corporation
131 patents
The Raymond Corporation
131 patents
VKR Holding A/S
131 patents
Xiamen University
131 patents
Butterfly Network, Inc.
130 patents
Crown Packaging Technology, Inc.
130 patents
Dalian Institute OF Chemical Physics, Chinese Academy OF Sciences
130 patents
Glaxo Group Limited
130 patents
Alcon Research, Ltd.
130 patents
What this shows Alcon holds 130 patents at rank #2,925, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,925 in granted patent volume.
Other assignees with the most granted patents in Alcon's primary technology class.
Two PlainPatent-derived peer sets for Alcon, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (49 here).
Nearest assignees by average claims per patent (15.6 here).
Alcon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 53 | 40.8% |
| 2016 | 35 | 26.9% |
| 2017 | 22 | 16.9% |
| 2018 | 11 | 8.5% |
| 2019 | 9 | 6.9% |
Top 15 of 40 technology areas
Overall rank by patents
#2,925
of 49,997 tracked assignees
48.5 out of 100
What to do with this data
Alcon Research, Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.